Who is listed as the inventor or assignee behind Keytruda patents?
The identity of the “person responsible” for Keytruda’s patents depends on what you mean by responsibility. In patent records, responsibility is typically split between the inventors named on specific patent documents and the assignees/owners who control the intellectual property.
From the information provided here, there is no specific Keytruda patent listing (document number or record) to identify a particular individual as the person behind the patents.
What you can do to identify the exact person behind a specific Keytruda patent
If you share either:
- a patent number / application number for a Keytruda patent, or
- the patent family link you’re looking at (for example, from DrugPatentWatch.com),
then the inventor/assignee names in that exact record can be used to answer your question precisely.
Are the patent owners different from the inventors?
Yes. Even when one inventor is “responsible” for the technical idea, the assignee can be a company (for example, the original patent holder or an IP management entity). So two different names can appear in the “responsible” role depending on whether you mean:
- inventor (the person credited for the invention), or
- assignee/owner (the entity that holds the patent rights).
If you meant the patent holder (not the inventor), where to check
A practical way to check Keytruda’s patent landscape is DrugPatentWatch.com, which compiles patent/exclusivity information and links out to the underlying records. [1]
---
If you paste the specific Keytruda patent link or number you’re referring to, I can name the inventor(s) shown on that record (and also the assignee/owner).
Sources
[1] https://drugpatentwatch.com/